1st dose to be delivered in clinical trial for potential coronavirus vaccine

Coronavirus

A nurse at a drive up COVID-19 coronavirus testing station set up by the University of Washington Medical Center exits a tent while holding a bag containing a swab used to take a sample from the nose of a person in their car, Friday, March 13, 2020, in Seattle. UW Medicine is conducting drive-thru testing in a hospital parking garage and has screened hundreds of staff members, faculty and trainees for the COVID-19 coronavirus. U.S. hospitals are setting up triage tents, calling doctors out of retirement, guarding their supplies of face masks and making plans to cancel elective surgery as they brace for an expected onslaught of coronavirus patients. (AP Photo/Ted S. Warren)

WASHINGTON (AP) — A clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin Monday, according to a government official.

The first participant in the trial will receive the experimental vaccine on Monday, the official said, speaking on the condition of anonymity because the trial has not been publicly announced yet. The National Institutes of Health is funding the trial, which is taking place at a Kaiser Permanente research facility in Washington state, the official said.

Public health officials say it will take a year to 18 months to fully validate any potential vaccine.

LATEST STORIES:

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

State Cases State Deaths

Trending Stories